Cardiovascular Pharmacology: Open Access

Show Articles
Journal Properties
  • Number of Articles
    199
  • Abbreviation
    Cardiovasc Pharm Open Access
  • e-ISSN
    2329-6607
  • Publisher
    OMICS Publishing Group
  • Indian UGC
  • DOAJ (latest)
Description
The journal Cardiovascular Pharmacology: Open Access is committed to the advancement of cardiovascular medicine by delivering accessible insights in pharmacology and therapeutics. Its key objective is to promote recent advances and clinical applications, original research articles, reviews, mini-reviews, and short communications encompassing topics such as molecular mechanisms of action, efficacy, safety, and clinical applications of drugs used in the management of cardiovascular diseases. It covers a broad spectrum of cardiovascular disorders such as hypertension, heart failure, arrhythmias, ischemic heart disease, and peripheral vascular disease. Additionally, the journal provides valuable insights into the application of pharmacological strategies in preventive cardiology. The journal offers a vital platform for researchers, clinicians, and pharmaceutical scientists to exchange findings and opinions, thus enabling evidence-based practices. It is indexed by major databases, and targets a global audience of cardiologists, pharmacologists, and healthcare professionals. ‘s commitment to open access ensures that the research is freely available and is used to enhance cardiovascular care and improve patient outcomes. The journal strives to offer high-quality, cutting-edge research in cardiovascular pharmacology to promote scientific progress and innovative therapies. Explore the current issue and submit your manuscript today!